Back to search results

CHAMP Lung Cancer Screening Program

This study is looking at ways to improve lung cancer screening for people aged 50-77 who have a history of smoking. It's testing two approaches: the DELFI Diagnostics FirstLook Lung Cancer Screening Blood Test, which involves a blood draw, or a Low-Dose CT Scan, which you would get through your doctor. The study wants to see how many people get screened for lung cancer. You can join if you are 50-77 years old, have smoked for at least 20 pack-years (meaning 20 packs of cigarettes per year for one year, or one pack per year for 20 years, etc.), and are a current smoker or quit within the last 15 years. The study is currently unclear on its status and plans to enroll 300 participants.

Study design
This is an interventional study, meaning participants will receive a specific test. It aims to enroll 300 participants.
What's involved
You would either provide a blood sample for the DELFI Diagnostics test or arrange for a low-dose CT scan through your doctor and share the results with the study.
Compensation
Not stated in the trial record.
Follow-up
The study will measure lung cancer screening participation from enrollment through six months after enrollment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07572773

CHAMP Lung Cancer Screening Program

Recruiting
NAAges 50–77InterventionalScreening
Jill Kolesar
~300 participants
Updated 2026-06-16 on ClinicalTrials.gov
What's tested:DELFI Diagnostics FirstLook Lung Cancer Screening Blood TestLow-Does CT Scan

At a glance

Recruiting sites
3 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of pharmacy patrons receiving lung cancer screening
Measured over From enrollment through six months after enrollment

Conditions

Lung Cancer
Early Lung Cancer Detection

Explore related trials

Lung Carcinoma

Where it's being run

3 sites across 1 states
Iowa3

Study leadership

  • Jill Kolesar, PharmD, MS, FCCP · PRINCIPAL_INVESTIGATOR · University of Iowa

Who to contact

Laura Seegmiller
[email protected]
(319) 384-1494
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

aged 50-77
smoking pack-year history of ≥ 20 years
current smoker or quit smoking 15 or less years ago
ability to understand and willingness to sign a written informed consent document

Exclusion

self-report of lung cancer screening in the last 12 months
psychiatric illness/social situations that would limit compliance with study requirements

What this trial measures

  • Proportion of pharmacy patrons receiving lung cancer screeningFrom enrollment through six months after enrollment

    To determine the proportion of pharmacy patrons eligible for lung cancer screening who accept a pharmacist's recommendation for screening and subsequently undergo lung cancer screening.